| AURINIA PHARMACEUT. |
| Kanada |
| Gesundheit |
| CA05156V1022 / A1W7D4 |
| IKAP (Frankfurt) / AUPH (NASDAQ) |
| FRA:IKAP, ETR:IKAP, IKAP:GR, NASDAQ:AUPH |
| - |
| https://www.auriniapharma.. |
|
Aurinia Pharmaceuticals Inc. is a biotechnology co..
>Volltext.. |
| 1508.7 Mio. EUR |
| 1310.18 Mio. EUR |
| 226.37 Mio. EUR |
| 88.97 Mio. EUR |
| 52.77 Mio. EUR |
| 0.38 EUR |
| 71.22 Mio. EUR |
| 46.13 Mio. EUR |
| 80.58 Mio. EUR |
| 4.03 |
| 14.2% |
| - |
| - |
| - |
| - |
| - |
| AURINIA |
| 04.11.25 |